Abbott Offers To Lower Price Of Antiretroviral Kaletra For Thai Government Health Programs
Tue, 13 Feb 2007 05:00 PM EST
... Pharmaceutical company Abbott Laboratories on Thursday in negotiations with Thailand's Ministry of Public Health agreed in principle to lower the price of its antiretroviral drug Kaletra in response to Thailand's announcement last month that it would issue a compulsory license for the drug, the Bangkok Post reports (Treerutkuarkul, Bangkok Post, 2/9). [click link for full article] ...
Related Topics
- Adalimumab
- Lopinavir and Ritonavir
- Lopinavir and Ritonavir Oral Solution
- Occupational Health
- Mental Health
- Health Insurance
- Grants & Cooperative Agreements
- Grants
- Health Care
- Exercise for Seniors
- Health Topics
- Health System
- Teen Health
- Sexual Health
- Health psychology
- Healthcare Workers
- Reproductive Health
- Women's Health
- Pets and Pet Health
- Public Health

Not Signed In -


